Systematic review and meta-analysis shows rTMS reduces post-stroke shoulder pain in stroke survivors.
Photo by CDC / Unsplash
Key Takeaway
Consider rTMS for post-stroke shoulder pain based on significant short-term pain reduction.
This systematic review and meta-analysis examined the efficacy of repetitive transcranial magnetic stimulation (rTMS) for managing post-stroke shoulder pain. The analysis included over 500 stroke survivors across multiple studies, with follow-up duration not reported. The primary outcome measured pain intensity using the visual analog scale or numeric rating scale.
secondary_outcomes included the Fugl-Meyer Assessment, Modified Barthel Index, and shoulder range of motion. The pooled effect size for pain intensity was a weighted mean difference of -1.62 with a 95% CI of -2.00 to -1.24 and a p-value less than 0.00001. Functional assessments also showed significant improvement, though specific effect sizes were not reported for these secondary outcomes.
The authors note that high-quality, multi-center randomized controlled trials with extended follow-up are warranted to confirm these findings. Safety data, including adverse events and tolerability, were not reported in the included studies. The review supports incorporating rTMS into stroke rehabilitation protocols while cautioning against overstatement of long-term benefits or optimization of stimulation parameters.
View Original Abstract ↓
BACKGROUND: Post-stroke shoulder pain (PSSP) is a common complication of stroke survivors, substantially impeding upper-limb functional recovery and diminishing quality of life. Conventional treatments usually target peripheral symptoms and only yield limited or transient benefits. Repetitive transcranial magnetic stimulation (rTMS) has shown analgesic potential in various neuropathic pain conditions, yet its efficacy in PSSP lacks systematic evaluation.
METHODS: Eight databases were systematically searched to identify randomized controlled trials evaluating rTMS interventions for PSSP. The primary outcome was pain intensity measured by the visual analog scale or numeric rating scale. Secondary outcomes included Fugl-Meyer Assessment, Modified Barthel Index, and shoulder range of motion. Risk assessment and data analysis were performed using Review Manager 5.4.1, with heterogeneity quantified by the I statistic and subgroup analyses conducted to explore its potential sources.
RESULTS: 12 RCTs involving over 500 participants met the inclusion criteria. Results revealed that rTMS significantly reduced pain intensity compared to control (WMD: -1.62; 95% CI: -2.00, -1.24; < 0.00001). Additionally, rTMS significantly improved the FMA, MBI scores and shoulder ROM.
CONCLUSION: rTMS appears to be a promising intervention for reducing PSSP and enhancing upper-limb motor function. These findings support incorporating rTMS into stroke rehabilitation protocols. In the future, high-quality, multi-center RCTs with extended follow-up are warranted to optimize stimulation parameters and validate long-term benefits.
Intravenous tenecteplase improves functional outcomes but increases hemorrhage risk in non-large vessel occlusion acute ischemic stroke.
Tenecteplase improves stroke recovery but increases bleeding risk in late treatment window
Related in Neurology
Aerobic and strength training reduce fatigue in multiple sclerosis patients
Aerobic or strength training eases MS fatigue, trial finds
This randomized effectiveness trial in 62 persons with multiple sclerosis and fatigue found that 8 weeks of aerobic training, strength train…
A small trial finds that aerobic and strength training each reduce fatigue in MS, with no clear winner among exercise types.
Modified CIMT with trunk restraint improves function in chronic stroke patients
Six weeks of tailored therapy improved function and quality of life for chronic stroke patients.
A single-blinded RCT in 34 chronic stroke patients found that adding patient-tailored modified constraint-induced movement therapy (mCIMT) w…
Thirty-four people with long-term stroke saw better movement and balance after six weeks of a specific therapy mix compared to standard care…
Laughter yoga reduced fatigue in people with multiple sclerosis in a randomized controlled trial
Laughter Yoga Cuts Fatigue And Improves Sleep For Multiple Sclerosis Patients
This randomized controlled trial enrolled 42 people with multiple sclerosis. Participants in the intervention group received 12 sessions of …
People with multiple sclerosis who practiced laughter yoga reported less tiredness and better sleep after just twelve sessions.
Exercise training improves cognition and fatigue in older adults with multiple sclerosis
Exercise boosts brain and cuts fatigue in older adults with MS
This Phase-Ib randomized controlled trial in 51 older adults with multiple sclerosis found that 16 weeks of home-based aerobic and resistanc…
A 16-week home exercise program improved thinking speed, executive function, fatigue, and quality of life in older adults with multiple scle…
From Other Specialties
SBRT plus atezolizumab shows activity in metastatic cervical cancer
Radiation plus immune therapy helps some patients with advanced cervical cancer survive longer
This prospective phase II trial evaluated SBRT followed by atezolizumab in 21 patients with metastatic, recurrent, or persistent cervical ca…
A small trial found that adding immune therapy to radiation helped some patients with advanced cervical cancer keep their disease stable for…
In-person group sessions boost fruit/vegetable intake in Latina breast cancer survivors
In-Person Sessions Boost Fruit and Vegetable Intake in Latina Breast Cancer Survivors
This randomized factorial trial in 167 Latina breast cancer survivors found that in-person group sessions increased daily fruit/vegetable in…
In-person group sessions helped Latina breast cancer survivors eat more fruits and vegetables, while the control group's intake dropped shar…
Capivasertib-paclitaxel fails to improve overall survival in metastatic TNBC
New drug combo did not extend life for metastatic triple-negative breast cancer patients in this trial
This phase III RCT in 812 patients with previously untreated metastatic triple-negative breast cancer found that adding capivasertib to pacl…
A large global trial found that adding capivasertib to paclitaxel did not improve overall survival for patients with metastatic triple-negat…
Contrast-enhanced mammography reduces costs per QALY in breast cancer screening recalls compared to conventional imaging
Contrast-enhanced mammography may cut costs for breast cancer screening
This RCT evaluated women recalled from breast cancer screening in a hospital setting. Contrast-enhanced mammography (CEM) as the primary too…
Using contrast-enhanced mammography as the first test for women recalled from screening could lower imaging costs without harming quality of…